Introduction {#sec1}
============

In 2010, approximately 15 million babies were born preterm worldwide, and more than one million died due to complications from preterm births (PTB). Neonates that survive PTB exhibit an increased risk of neurodevelopmental impairments and respiratory complications [@bib1]. The proportion of spontaneous PTB attributed to infection is approximately 50% [@bib2]. However, a pathogen is identified in only one third of the cases, despite evidence of infection. Obligate intracellular bacteria, which do not grow on media used routinely to isolate human pathogens from clinical samples, might represent possible agents of PTB.

*Chlamydia trachomatis,* an obligate intracellular bacterium, is considered the world\'s most common sexually transmitted bacterial pathogen. *Waddlia chondrophila* is another member of the Chlamydiales order that has been shown to cause abortions in bovines [@bib3]. Both of these intracellular bacteria have also been implicated in human adverse pregnancy outcomes [@bib4; @bib5; @bib6; @bib7]. In addition, *C. trachomatis* is known to cause premature rupture of the membranes and premature uterine activity, and growing evidence suggests a role for *C. trachomatis* in PTB [@bib8]. In this study, we investigated the role of *Waddlia* and *Chlamydia* as emerging agents of PTB. We studied 407 women with PTBs or uneventful term pregnancies attending the University Hospital of Lausanne, Lausanne, Switzerland. In addition to serology, we also performed PCR to detect *Waddlia* and *Chlamydia* in the placenta and vaginal samples taken from these women, as well as histology on the placenta.

From 2006 to 2009, 407 women were enrolled into this study at the obstetrical ward of the University Hospital of Lausanne. The PTB group (*n* = 146) included women who spontaneously delivered before 37 weeks\' gestation. The control group (*n* = 261) included women attending a labour ward with uneventful term pregnancies and no history of miscarriages, stillbirths or preterm labour. We compared demographic data and risk factors of patients with and without PTB or *C. trachomatis* infection by the Pearson χ^2^ test (or the Fisher exact test when indicated) for categorical variables. For continuous variables, medians were compared by the Wilcoxon-Mann-Whitney test. Multivariable analyses were performed to control for covariates. Statistical analyses were performed using the Stata software, version 13.0 (StataCorp, College Station, TX, USA).

Only positive urine cultures, gestational and maternal age were significantly different between control and PTB groups ([Table 1](#tbl1){ref-type="table"}). Other infectious causes were investigated in the PTB group, showing that a positive culture was found in the vagina, maternal or fetal side of the placenta in 32%, 37% and 17% of the PTB patients, respectively ([Supplementary Table 1](#appsec1){ref-type="sec"}). Among all these bacterial species, genital mycoplasma and *Gardnerella vaginalis,* which have been previously associated with PTB [@bib9], were recovered in some subjects from the vagina only (*n* = 25 and 3, respectively), never from the placenta.

Sera were tested for antibodies directed against *C. trachomatis* and *W. chondrophila*, respectively, by using the MOMP-R, CT pELISA (R-biopharm, Darmstadt, Germany) [@bib10] and *Waddlia*-specific immunofluorescence as described elsewhere [@bib6]. Isolated IgG mainly reflects past or chronic infection, whereas IgM and/or IgA reflect acute infection. Briefly, *W. chondrophila* strain ATCC VR-1470 was used as antigen, whereas Fluoline G or M (bioMérieux, Marcy l\'Étoile, France) were used as secondary antibodies. An antibody titre of ≥1/64 for IgG and ≥1/32 for IgM were considered as positive, respectively [@bib6]. There was no difference between control and PTB groups in terms of anti-*Chlamydia* IgG and IgA and anti-*Waddlia* IgG and IgM titres ([Table 1](#tbl1){ref-type="table"}). A total of 54 patients tested positive only for *Waddlia* IgG and 26 only for *Chlamydia* IgG, indicating the absence of serologic cross-reaction between both pathogens. Only six patients tested positive for both *Waddlia* and *Chlamydia* IgG (p 0.446).

*C. trachomatis* IgG seropositivity ([Table 2](#tbl2){ref-type="table"}) was associated with civil status (divorced vs. married, odds ratio (OR) 7.85; 95% confidence interval (CI) 2.61--23.62), education (OR 0.28; 95% CI 0.10--0.81) and number of previous sexual partners (\>6 vs. 1: OR 13.12, 95% CI 1.53--112.32; "not answered" vs. 1: OR 13.55, 95% CI 1.76--104.09). Patients who used condoms as a previous contraceptive method show less *C. trachomatis* positive serologies, although this was not statistically significant. Of note, only six (55%) and one (9%) of the 11 patients positive for *C. trachomatis* DNA were also positive for *C. trachomatis* IgG and IgA, respectively. However, *C. trachomatis* IgG-positive patients exhibited significantly more histologic chorioamnionitis (50%) than *C. trachomatis* IgG-negative patients (28.3%, p 0.015).

*Waddlia* seropositivity was not associated with age, number of lifelong sexual partners, place of residence (rural vs. urban), smoking, pet ownership or meat consumption (data not shown). Interestingly, 4.9% of women of European heritage vs. 14.3% of those of non-European heritage had positive *Waddlia* IgG serologies of ≥1/256 (p 0.008). This correlation was also observed for *Waddlia* IgM of ≥1/32 (3.6% of European vs. 10.4% of non-European, p 0.034). Among non-European women, the highest *Waddlia* IgG titres (≥1/128 or ≥1/256) were more frequent for black ethnicity (20% and 14.3%, respectively). When total immunoglobulin (Ig ≥1/64) against *Waddlia* was considered, condoms as a previous contraceptive method protected against *Waddlia* infection (12.1% condom users vs. 21.4% of the noncondom users exhibited anti-*Waddlia* Ig reactivity, p 0.041).

After DNA extraction with QIAamp DNA Mini Kit (Qiagen, Hilden, Germany), all vaginal swabs and placenta samples were screened for *C. trachomatis* DNA by a TaqMan real-time PCR targeting the cryptic plasmid of *C. trachomatis*, as described earlier [@bib11]. Samples were also tested by a 16S rRNA *Waddlia*-specific real-time PCR, as described previously [@bib12]. No PCR inhibition was observed for either pathogen. Vaginal and placental samples from the PTB group were significantly more often *C. trachomatis* DNA positive than the control group (p 0.002, unadjusted OR 8.51; 95% CI 1.81--39.93). This association reminded significant even after adjustment for maternal age, origin, civil status, education, number of sexual partners and positive urine cultures (OR 7.93; 95% CI 1.34--46.76). Stepwise logistic regression allowed us to confirm that the presence of *C. trachomatis* DNA is an independent factor associated with PTB ([Fig. 1](#fig1){ref-type="fig"}). There was no difference between the control and PTB groups regarding *Waddlia* PCR results. Thirty-four patients were positive only for *W. chondrophila,* whereas ten other subjects were positive only for *C. trachomatis* by PCR. Only one patient was positive for both, demonstrating the absence of cross-amplification of these two obligate intracellular bacteria. Presence of *Waddlia* DNA was demonstrated in the genital tract or placenta of 13 PTB subjects ([Table 3](#tbl3){ref-type="table"}). Seven of them had more than one miscarriage in their medical history. Of these 13 patients, four exhibited both a positive *Waddlia* serology and presence of *Waddlia* DNA. Two had presence of *Waddlia* in multiple samples, including vaginal swab, urine and placenta. Only two of these 13 patients had either a positive *C. trachomatis* serology or PCR. Ten of these 13 patients had abnormal placenta histologies.

Discussion {#sec2}
==========

Both *C. trachomatis* and *W. chondrophila* have been implicated in adverse pregnancy outcomes [@bib4; @bib5; @bib7; @bib8]. However, there have been contradictory findings pertaining to the role of *C. trachomatis* infection in PTB. A few small studies have failed to demonstrate a risk of PTB associated with *C. trachomatis* infections [@bib13; @bib14], although several large, well-conducted studies have supported a role for *C. trachomatis* in PTB [@bib15; @bib16; @bib17]. Thus, in a large study including 4055 subjects, about 15% of PTB was attributed to *C. trachomatis* [@bib16].

We have previously confirmed an association between *Waddlia* antibodies and human miscarriage and have demonstrated its presence in placenta and/or genital tract [@bib4; @bib5; @bib6; @bib7]. In the present study, *W. chondrophila* was not associated with PTB despite inflammation, and abnormal histology of the placenta was observed among patients infected by *Waddlia* (positive PCR). Women of African descent were more likely to have positive *Waddlia* serology. Moreover, condom use was inversely associated with *Waddlia* seropositivity.

In contrast to *Waddlia,* presence of *Chlamydia* DNA in the genital tract and/or in the placenta was strongly associated with PTB. However, *C. trachomatis* seropositivity did not correlate with PTB, suggesting that acute rather than chronic *C. trachomatis* infection is associated with PTB. Interestingly, these results are opposite to our previous findings, in which we demonstrated that both chronic and acute *C. trachomatis* infections correlate with miscarriages [@bib18]. Our results confirm those of a population-based prospective study recently published in the Generation R cohort in the Netherlands [@bib16]. In this large study (\>4000 pregnant women), *Chlamydia* DNA was strongly associated with PTB but not with miscarriage or perinatal death. Conflicting data between *Chlamydia* DNA, serology and pregnancy outcomes may reflect different pathophysiologic mechanisms, in which *Chlamydia*-induced miscarriages are the result of an immunologic process, whereas the direct impact of the bacteria results in *Chlamydia*-induced PTB.

A limitation of our study was the absence of investigation of other infectious etiology of PTB in all patients (PTB and control subjects). Some pathogens can reach the placenta by hematogenous spread or by an ascending route from the cervix. Among bacterial infections, *Ureaplasma urealyticum, Mycoplasma hominis* and bacterial vaginosis have been associated with PTB, but controversies regarding their true role during pregnancy persist [@bib9; @bib19].

Overall, these results strongly suggest a role of acute *C. trachomatis* infection in PTB, and we strongly recommend systematically testing for *C. trachomatis* in any woman at risk for or after preterm delivery.
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###### 

Characteristics of patients according to term history

  Characteristic                            Control (n = 261)   PTB (n = 146)   p
  ----------------------------------------- ------------------- --------------- ---------
  Gestational age at birth, weeks, ±SD      39.6 ± 1.1          32.6 ± 3.3      \<0.001
  Age, years, ±SD                           31.5 ± 5.0          32.4 ± 5.9      0.057
   \<35 years                               194 (74.3%)         94 (64.4%)      0.041
   ≥35 years                                67 (25.7%)          52 (35.6%)      
  Parity, ±SD                               0.5 ± 0.8           0.5 ± 0.8       0.950
   0                                        160 (61.3%)         95 (65.1%)      0.228
   1                                        72 (27.6%)          30 (20.6%)      
   \>1                                      29 (11.1%)          21 (14.4%)      
  Origin                                                                        
   European                                 217 (83.1%)         113 (77.4%)     0.156
   Non-European                             44 (16.9%)          33 (22.6%)      
  Civil status                                                                  
   Married                                  201 (77.0%)         109 (74.7%)     0.739
   Single                                   49 (18.8%)          32 (21.9%)      
   Divorced                                 11 (4.2%)           5 (3.4%)        
  Education                                                                     
   Nonuniversity studies                    170 (65.1%)         106 (72.6%)     0.150
   University studies                       91 (34.9%)          40 (27.4%)      
  No. of lifelong sexual partners                                               
   1                                        58 (22.2%)          37 (25.3%)      0.393
   2--3                                     43 (16.5%)          29 (19.9%)      
   4--6                                     45 (17.2%)          19 (13.0%)      
   \>6                                      36 (13.8%)          13 (8.9%)       
   Not answered                             79 (30.3%)          48 (32.9%)      
  Condom as previous contraceptive method   69 (26.4%)          33 (22.6%)      0.407
  Smoking status                                                                
   Nonsmoker                                224 (85.8%)         129 (88.4%)     0.543
   Smoker                                   37 (14.2%)          17 (11.6%)      
  Pets at home                              82 (31.4%)          39 (26.7%)      0.366
  Vegetarian                                5 (1.9%)            5 (3.4%)        0.341
  *Chlamydia trachomatis* serology                                              
   IgG positive                             19 (7.3%)           13 (8.9%)       0.569
   IgA positive                             10 (3.8%)           9 (6.2%)        0.330
   Both IgG and IgA positive                7 (2.7%)            7 (4.8%)        0.270
  *C. trachomatis* PCR                                                          
   Cervicovaginal swab                      2 (0.7%)            7 (4.8%)        0.012
   Placenta                                 2 (0.7%)            7 (4.8%)        0.012
   At least one PCR positive                2 (0.7%)            9 (6.2%)        0.002
  *Waddlia* serology                                                            
   Total Ig ≥1/64                           47 (18.0%)          31 (21.2%)      0.428
   IgG ≥1/64                                38 (14.6%)          22 (15.1%)      0.889
   IgM ≥1/16                                9 (3.5%)            11 (7.5%)       0.092
  *Waddlia* PCR                                                                 
   Cervico-vaginal swab                     11 (4.2%)           10 (6.9%)       0.252
   Placenta                                 11 (4.2%)           4 (2.7%)        0.587
  Other infections                                                              
   Positive urine culture                   7 (2.7%)            38 (26%)        \<0.001
   *Streptococcus agalactiae*               45 (18.0%)          22 (17.5%)      1.000
   *Brucella abortus*                       19 (7.3%)           11 (7.5%)       1.000
   *Parachlamydia acanthamoebae*            2 (0.8%)            0 (0%)          0.539
   *Simkania negevensis*                    3 (1.2%)            1 (0.7%)        1.000

PTB, preterm birth.

###### 

Characteristics of patients according to *Chlamydia trachomatis* serologic status

  Characteristic                            IgG negative (n = 375, 92.1%)   IgG positive (n = 32, 7.9%)   p
  ----------------------------------------- ------------------------------- ----------------------------- ---------
  Age, years, ±SD                           31.9 ± 5.3                      30.9 ± 6.5                    0.298
   \<35 years                               263 (91.3%)                     25 (8.7%)                     0.421
   ≥35 years                                112 (94.1%)                     7 (5.9%)                      
  Parity, ±SD                               0.5 ± 0.8                       0.5 ± 0.7                     0.997
   0                                        233 (91.4%)                     22 (8.6%)                     0.38
   1                                        97 (95.1%)                      5 (4.9%)                      
   \>1                                      45 (90%)                        5 (10.0%)                     
  Origin                                                                                                  
   European                                 307 (93.0%)                     23 (7.0%)                     0.164
   Non-European                             68 (88.3%)                      9 (11.7%)                     
  Civil status                                                                                            
   Married                                  288 (92.9%)                     22 (7.1%)                     \>0.001
   Single                                   77 (95.1%)                      4 (4.9%)                      
   Divorced                                 10 (62.5%)                      6 (37.5%)                     
  Education                                                                                               
   Nonuniversity studies                    248 (89.9%)                     28 (10.1%)                    0.017
   University studies                       127 (97.0%)                     4 (3.1%)                      
  No. of lifelong sexual partners                                                                         
   1                                        94 (99.0%)                      1 (1.0%)                      0.006
   2--3                                     66 (91.7%)                      6 (8.3%)                      
   4--6                                     61 (95.3%)                      3 (4.7%)                      
   \>6                                      43 (87.8%)                      6 (12.2%)                     
   Not answered                             111 (87.4%)                     16 (12.6%)                    
  Place of residence                                                                                      
   Rural                                    126 (91.3%)                     12 (8.7%)                     0.699
   City                                     249 (92.6%)                     20 (7.4%)                     
  Condom as previous contraceptive method                                                                 
   No                                       277 (90.8%)                     28 (9.2%)                     0.094
   Yes                                      98 (96.1%)                      4 (3.9%)                      
  Smoking status                                                                                          
   Nonsmoker                                209 (95.0%)                     11 (5.0%)                     0.114
   Smoker                                   48 (88.9%)                      6 (11.1%)                     

###### 

Clinical history, serology, PCR and placental histology of preterm patients with samples positive for *Waddlia* by real-time PCR

  Patient no.   Maternal age, years   No. pregnancies   Parity   Gestational age at birth, weeks   Birth weight, g   Country of origin   *Waddlia*   Placental histology   Other possible etiologies[a](#tbl3fna){ref-type="table-fn"}                                                                                
  ------------- --------------------- ----------------- -------- --------------------------------- ----------------- ------------------- ----------- --------------------- ------------------------------------------------------------- ---------------------------------------------------------------------------- ------------------------------------------------------------
  17            37                    2                 0        35.3                              2520              Switzerland         ---         ---                   P                                                             Calcifications                                                               
  28            35                    10                4        31.5                              1870              Angola              ---         ---                   P and VS                                                      Subchorial fibrin, necrosis, lymphocytes in chorion and amnion, vasculitis   
  45            27                    1                 0        34.1                              2340              Switzerland         ---         ---                   VS                                                            ---                                                                          
  66            29                    1                 0        25.6                              890               Portugal            ---         ---                   VS                                                            Subchorial fibrin, lymphocytes in chorion and amnion, oedema                 
  133           40                    2                 1        30.5                              1270              Togo                1/128       ---                   VS                                                            Villous oedema                                                               
  185           33                    2                 0        35.1                              2060              Switzerland         ---         ---                   VS                                                            Villous oedema                                                               
  223           32                    2                 0        36.3                              2370              Portugal            ---         ---                   VS                                                            ---                                                                          CT IgG and IgA positive[b](#tbl3fnb){ref-type="table-fn"}
  261           39                    4                 0        34.4                              2540              Italy               1/128       ---                   P                                                             Decidual fibrin                                                              
  283           34                    4                 1        36.4                              2560              Congo               1/256       ---                   VS                                                            Subchorial fibrin                                                            
  314           36                    1                 0        31.3                              1310              Switzerland         ---         ---                   VS                                                            ---                                                                          
  351           33                    2                 0        35.3                              2280              Italy               1/128       1/32                  VS                                                            Marginal hemorrhage                                                          
  476           35                    2                 1        30                                1530              Italy               ---         ---                   VS                                                            Lymphocytes in decidua                                                       
  572           26                    1                 0        35                                1920              Switzerland         ---         ---                   P and U                                                       Intervillous hemorrhage                                                      CT PCR positive placenta[c](#tbl3fnc){ref-type="table-fn"}

Haematoxylin and eosin--stained histologic sections of all placenta specimens were examined for the type and degree of placentitis, endometritis and/or vasculitis by a pedopathologist.

P, placenta; VS, vaginal swab; U, urine; CT, *C. trachomatis.*

All patients were also tested for *C. trachomatis, Brucella abortus, Streptococcus agalactiae, Parachlamydia acanthamoebae* and *Simkania negevensis*.

Positive serology for *C. trachomatis* observed in this case reflects a possible coinfection because there is no serologic cross-reaction between *C. trachomatis* and *Waddlia chondrophila,* and because the *W. chondrophila* serology was negative.

*C. trachomatis* positive PCR reflects a likely coinfection because there is no cross-amplification with the PCRs we used.
